Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors
- 1 April 2001
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 110 (5) , 339-346
- https://doi.org/10.1016/s0002-9343(01)00629-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A long term follow-up of a randomized trial comparing interferon-α with busulfan for chronic myelogenous leukemiaLeukemia Research, 1998
- Interferon Alfa Versus Chemotherapy for Chronic Myeloid Leukemia: A Meta-analysis of Seven Randomized TrialsJNCI Journal of the National Cancer Institute, 1997
- Unrelated marrow donor registriesCurrent Opinion in Hematology, 1997
- UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic responseThe Lancet, 1995
- Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α TherapyAnnals of Internal Medicine, 1995
- Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid LeukemiaNew England Journal of Medicine, 1994
- Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia.Journal of Clinical Oncology, 1993
- Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor ProgramNew England Journal of Medicine, 1993
- Indications for marrow transplantation in chronic myelogenous leukemia [see comments]Blood, 1989
- Bone Marrow Transplantation for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1986